Core Scientific, Inc. (NASDAQ:CORZ) Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH decreased its holdings in shares of Core Scientific, Inc. (NASDAQ:CORZ) by 98.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 10,600 shares of the company’s stock after selling 617,646 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Core Scientific were worth $77,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CORZ. FMR LLC increased its position in Core Scientific by 2,937.7% during the 4th quarter. FMR LLC now owns 7,436,229 shares of the company’s stock worth $104,479,000 after purchasing an additional 7,191,428 shares during the period. Driehaus Capital Management LLC boosted its stake in shares of Core Scientific by 112.1% during the 4th quarter. Driehaus Capital Management LLC now owns 10,264,204 shares of the company’s stock worth $144,212,000 after acquiring an additional 5,424,901 shares in the last quarter. Fred Alger Management LLC purchased a new stake in shares of Core Scientific during the 4th quarter worth approximately $62,011,000. Beryl Capital Management LLC boosted its stake in shares of Core Scientific by 24.3% during the 4th quarter. Beryl Capital Management LLC now owns 18,179,586 shares of the company’s stock worth $255,423,000 after acquiring an additional 3,548,396 shares in the last quarter. Finally, Jericho Capital Asset Management L.P. purchased a new stake in shares of Core Scientific during the 4th quarter worth approximately $39,240,000.

Insider Buying and Selling at Core Scientific

In other Core Scientific news, insider Todd M. Duchene sold 7,759 shares of the business’s stock in a transaction on Wednesday, June 25th. The shares were sold at an average price of $12.39, for a total transaction of $96,134.01. Following the sale, the insider directly owned 2,049,689 shares of the company’s stock, valued at $25,395,646.71. The trade was a 0.38% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Yadin Rozov bought 110,000 shares of the business’s stock in a transaction on Wednesday, May 28th. The shares were purchased at an average cost of $10.87 per share, for a total transaction of $1,195,700.00. Following the completion of the purchase, the director owned 475,687 shares in the company, valued at approximately $5,170,717.69. This trade represents a 30.08% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have sold 117,759 shares of company stock worth $1,391,434. Company insiders own 1.40% of the company’s stock.

Core Scientific Stock Up 3.2%

Shares of NASDAQ:CORZ opened at $14.08 on Wednesday. The company’s fifty day moving average is $13.35 and its two-hundred day moving average is $11.00. Core Scientific, Inc. has a 12-month low of $6.20 and a 12-month high of $18.63. The company has a market cap of $4.19 billion, a P/E ratio of -2.80 and a beta of 6.60.

Core Scientific (NASDAQ:CORZ) last announced its earnings results on Wednesday, May 7th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.02. The firm had revenue of $79.53 million for the quarter, compared to analyst estimates of $92.04 million. During the same period last year, the firm earned $0.78 earnings per share. Core Scientific’s revenue for the quarter was down 55.6% compared to the same quarter last year. Equities research analysts anticipate that Core Scientific, Inc. will post 0.52 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on CORZ. Barclays lowered Core Scientific to an “underweight” rating in a research note on Tuesday, July 8th. Citizens Jmp lowered Core Scientific from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 14th. Roth Capital reissued a “neutral” rating and set a $20.00 price target on shares of Core Scientific in a research note on Tuesday, July 8th. Roth Mkm reissued a “buy” rating and set a $20.00 price target on shares of Core Scientific in a research note on Thursday, June 26th. Finally, Canaccord Genuity Group reaffirmed a “buy” rating and issued a $17.00 target price on shares of Core Scientific in a research note on Friday, June 27th. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $18.32.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.